Related Experiment Video
Updated: Dec 9, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding
Andrea Iannucci1,2, Valeria Caneparo1,2, Stefano Raviola1,2
1CAAD-Center for Translational Research on Autoimmune and Allergic Disease, University of Eastern Piedmont, Novara, Italy.
Abstract:
Damage-associated molecular patterns (DAMPs) are endogenous molecules activating the immune system upon release from injured cells. Here we show that the IFI16 protein, once freely released in the extracellular milieu of chronically inflamed tissues, can function as a DAMP either alone or upon binding to lipopolysaccharide (LPS). Specifically, using pull-down and saturation binding experiments, we show that IFI16 binds with high affinity to the lipid A moiety of LPS. Remarkably, IFI16 DAMP activity is potentiated upon binding to subtoxic concentrations of strong TLR4-activating LPS variants, as judged by TLR4-MD2/TIRAP/MyD88-dependent IL-6, IL-8 and TNF-α transcriptional activation and release in stimulated monocytes and renal cells. Consistently, using co-immunoprecipitation (co-IP) and surface plasmon resonance (SPR) approaches, we show that IFI16 is a specific TLR4-ligand and that IFI16/LPS complexes display a faster stimulation turnover on TLR4 than LPS alone. Altogether, our findings point to a novel pathomechanism of inflammation involving the formation of multiple complexes between extracellular IFI16 and subtoxic doses of LPS variants, which then signal through TLR4.
Insights
Extracellular IFI16 protein acts as a damage-associated molecular pattern (DAMP), binding lipopolysaccharide (LPS). These IFI16/LPS complexes enhance immune responses via TLR4 signaling, revealing a new inflammation pathway.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Damage-associated molecular patterns (DAMPs) are endogenous molecules released from injured cells, activating the immune system.
- Chronic inflammation involves complex molecular interactions that perpetuate immune responses.
Purpose of the Study:
- To investigate the role of extracellular IFI16 protein as a DAMP.
- To determine if IFI16 interacts with lipopolysaccharide (LPS) and modulates immune signaling.
Main Methods:
- Pull-down and saturation binding assays to assess IFI16-LPS interaction.
- Co-immunoprecipitation (co-IP) and surface plasmon resonance (SPR) to characterize IFI16 as a TLR4 ligand.
- Measurement of IL-6, IL-8, and TNF-α release in stimulated monocytes and renal cells.
Main Results:
- IFI16 binds with high affinity to the lipid A moiety of LPS.
- IFI16 potentiates LPS-induced immune activation via TLR4-MD2/TIRAP/MyD88 pathway.
- IFI16 forms complexes with LPS that signal through TLR4 more rapidly than LPS alone.
Conclusions:
- Extracellular IFI16 functions as a DAMP, particularly when bound to LPS.
- IFI16/LPS complexes represent a novel mechanism for initiating and sustaining inflammation through TLR4 signaling.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
07:55A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
Related Concept Videos
Formation of Lipopolysaccharides
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The Extrinsic Apoptotic Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Signal Transduction: Overview
Typically, signal transduction involves three...